Main > ONCOLOGY (**) > Liver Cancer *** > Treatment. > USA. B. HCC>TREAT.>NivoluMAb+>*

---

USA. B. HCC>TREAT.>NivoluMAb+>*'s subsections
(*) USA Approval Date: 2020. 03.11.
+IpilimuMAb
>Previously Treated with Sorafenib
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2020. 03.10.
PR Web-Site
TradeMark

USA. B. HCC>TREAT.>NivoluMAb+>*'s products
This section has no products